Two Insulin Plans After Surgery and Wound Infections in Type 2 Diabetes
Compares two insulin plans after surgery in adults with type 2 diabetes.
Plain-language title generated from the registry record
Registry title: Postoperative Basal Bolus or Sliding Scale Insulin Regimen in DM2 and Its Effect on Surgical Site Infections.
Key facts
- Where
- Amsterdam, NetherlandsSee the site
Where in Netherlands
- Amsterdam UMCAmsterdam, NetherlandsTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Abraham Hulst, MD, PhD
- Trial code
- NCT06638567
- Record updated
- 30 January 2025
- Original description
A multicentre, matched-pair, cluster randomised controlled superiority trial to investigate the effect of a proactive basal bolus insulin regimen compared to the reactive sliding scale insulin regimen, targeting a glucose level of 3.9-10.0 mmol/L, to reduce the number of surgical site infections within the first 30 days postoperatively in adult patients with diabetes mellitus type 2.Read full original descriptionShow less
Postoperative Glucose Control with a Basal Bolus Versus Sliding Scale Insulin Regimen and Its Effect on the Incidence of Surgical Site Infections in People with Type 2 Diabetes Mellitus.
A multicentre, matched-pair, cluster randomised controlled superiority trial to investigate the effect of a proactive basal bolus insulin regimen compared to the reactive sliding scale insulin regimen, targeting a glucose level of 3.9-10.0 mmol/L, to reduce the number of surgical site infections within the first 30 days postoperatively in adult patients with diabetes mellitus type 2.
Inclusion: Patients aged 18 or older; Diagnosed with type 2 diabetes mellitus; Undergoing gastointestinal or vascular surgery; Admitted to one of the participating surgical wards; Expected duration of stay at least one overnight stay; Willing and able to provide informed consent.
Exclusion: Undergoing bariatric surgery; Diagnosed with type 1 diabetes mellitus; Female of child-bearing potential who is pregnant or breastfeeding; Undergoing complete pancreatectomy; Patients using a continuous insulin pump at home; Patients undergoing a necrotectomy/wound debridement from a pre-existent wound.